Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort study

IntroductionAn open dialogue between parents of children with cancer and medical staff about the benefits, risks, and interactions of complementary medicine used during cancer treatment is essential to enhance treatment safety and efficacy. However, both parents and medical staff often lack sufficie...

Full description

Saved in:
Bibliographic Details
Main Authors: Lara Nowak, Daniela Reis, Rebecca Büttner, Melanie Schwermer, Jennifer Bals, David D. Martin, Thomas Ostermann, Alfred Längler, Heidemarie Haller, Tycho Zuzak
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2025.1567053/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850183940991614976
author Lara Nowak
Daniela Reis
Rebecca Büttner
Melanie Schwermer
Jennifer Bals
David D. Martin
David D. Martin
Thomas Ostermann
Alfred Längler
Alfred Längler
Heidemarie Haller
Tycho Zuzak
Tycho Zuzak
author_facet Lara Nowak
Daniela Reis
Rebecca Büttner
Melanie Schwermer
Jennifer Bals
David D. Martin
David D. Martin
Thomas Ostermann
Alfred Längler
Alfred Längler
Heidemarie Haller
Tycho Zuzak
Tycho Zuzak
author_sort Lara Nowak
collection DOAJ
description IntroductionAn open dialogue between parents of children with cancer and medical staff about the benefits, risks, and interactions of complementary medicine used during cancer treatment is essential to enhance treatment safety and efficacy. However, both parents and medical staff often lack sufficient knowledge and willingness to engage in such discussions. To address this, bedside counseling for patients and families is proposed, provided directly by an external team comprising experienced specialists in complementary and conventional medicine. This approach aims to facilitate communication, improve understanding, and mitigate risks associated with complementary medicine during pediatric cancer care.MethodsThis study will be conducted in five pediatric cancer centers in Germany. Physicians specializing in complementary medicine and pediatric oncology will provide bedside counseling to patients, parents, and local medical staff. Feasibility and change measures will be evaluated by comparing cohorts of parents who received complementary medicine counseling with those who did not, as well as medical staff before and after training sessions. Semi-structured interviews with parents and medical staff will further explore barriers to complementary medicine counseling and identify strategies to enhance its implementation. Quantitative data will be analyzed to assess the feasibility of the intervention, while qualitative data will provide in-depth insights into the perspectives and experiences of stakeholders.ResultsThe results will highlight predictors for effective, use-oriented counseling tailored to different target groups. This prototype support care model will serve as a framework for implementing complementary medicine counseling both within and beyond inpatient pediatric oncology settings. By integrating these findings, we aim to develop a replicable approach to complementary medicine counseling that addresses the unique needs of pediatric cancer patients, their families, and medical professionals.DiscussionPrevious initiatives have primarily focused on training individual physicians within each center to address complementary medicine. In contrast, this novel strategy emphasizes direct bedside counseling for pediatric patients and families while providing ongoing support to local staff. This approach seeks to enhance treatment safety by reducing unintended interactions between complementary medicine and conventional cancer therapies, ultimately improving care quality and patient outcomes.Trial RegistrationGerman Clinical Trials Register (DRKS), ID: DRKS00030478. Registered 22 December 2022 https://www.drks.de/DRKS00030478.
format Article
id doaj-art-cf6581e40fe94121bc9d3c08bf985b0e
institution OA Journals
issn 2296-2360
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj-art-cf6581e40fe94121bc9d3c08bf985b0e2025-08-20T02:17:10ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602025-04-011310.3389/fped.2025.15670531567053Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort studyLara Nowak0Daniela Reis1Rebecca Büttner2Melanie Schwermer3Jennifer Bals4David D. Martin5David D. Martin6Thomas Ostermann7Alfred Längler8Alfred Längler9Heidemarie Haller10Tycho Zuzak11Tycho Zuzak12Department of Pediatrics, Gemeinschaftskrankenhaus, Herdecke, GermanyDepartment of Pediatrics, Gemeinschaftskrankenhaus, Herdecke, GermanyDepartment of Pediatrics, Gemeinschaftskrankenhaus, Herdecke, GermanyDepartment of Pediatrics, Gemeinschaftskrankenhaus, Herdecke, GermanyDepartment of Pediatrics, Gemeinschaftskrankenhaus, Herdecke, GermanyFaculty of Health, Universität Witten/Herdecke, Herdecke, GermanyPediatric Hospital, Universitätsklinikum Tübingen, Tübingen, GermanyDepartment of Psychology and Psychotherapy, Witten/Herdecke University, Witten, GermanyDepartment of Pediatrics, Gemeinschaftskrankenhaus, Herdecke, GermanyProfessorship for Integrative Pediatrics, Institute for Integrative Medicine, Witten/Herdecke University, Witten, GermanyCenter for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Pediatrics, Gemeinschaftskrankenhaus, Herdecke, GermanyFaculty of Medicine, University of Duisburg-Essen, Essen, GermanyIntroductionAn open dialogue between parents of children with cancer and medical staff about the benefits, risks, and interactions of complementary medicine used during cancer treatment is essential to enhance treatment safety and efficacy. However, both parents and medical staff often lack sufficient knowledge and willingness to engage in such discussions. To address this, bedside counseling for patients and families is proposed, provided directly by an external team comprising experienced specialists in complementary and conventional medicine. This approach aims to facilitate communication, improve understanding, and mitigate risks associated with complementary medicine during pediatric cancer care.MethodsThis study will be conducted in five pediatric cancer centers in Germany. Physicians specializing in complementary medicine and pediatric oncology will provide bedside counseling to patients, parents, and local medical staff. Feasibility and change measures will be evaluated by comparing cohorts of parents who received complementary medicine counseling with those who did not, as well as medical staff before and after training sessions. Semi-structured interviews with parents and medical staff will further explore barriers to complementary medicine counseling and identify strategies to enhance its implementation. Quantitative data will be analyzed to assess the feasibility of the intervention, while qualitative data will provide in-depth insights into the perspectives and experiences of stakeholders.ResultsThe results will highlight predictors for effective, use-oriented counseling tailored to different target groups. This prototype support care model will serve as a framework for implementing complementary medicine counseling both within and beyond inpatient pediatric oncology settings. By integrating these findings, we aim to develop a replicable approach to complementary medicine counseling that addresses the unique needs of pediatric cancer patients, their families, and medical professionals.DiscussionPrevious initiatives have primarily focused on training individual physicians within each center to address complementary medicine. In contrast, this novel strategy emphasizes direct bedside counseling for pediatric patients and families while providing ongoing support to local staff. This approach seeks to enhance treatment safety by reducing unintended interactions between complementary medicine and conventional cancer therapies, ultimately improving care quality and patient outcomes.Trial RegistrationGerman Clinical Trials Register (DRKS), ID: DRKS00030478. Registered 22 December 2022 https://www.drks.de/DRKS00030478.https://www.frontiersin.org/articles/10.3389/fped.2025.1567053/fullpediatric cancerintegrative cancer treatmentcomplementary medicinesafetystudy protocol
spellingShingle Lara Nowak
Daniela Reis
Rebecca Büttner
Melanie Schwermer
Jennifer Bals
David D. Martin
David D. Martin
Thomas Ostermann
Alfred Längler
Alfred Längler
Heidemarie Haller
Tycho Zuzak
Tycho Zuzak
Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort study
Frontiers in Pediatrics
pediatric cancer
integrative cancer treatment
complementary medicine
safety
study protocol
title Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort study
title_full Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort study
title_fullStr Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort study
title_full_unstemmed Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort study
title_short Bedside counseling on complementary medicine as a new model in pediatric cancer care—protocol of the SiKOM multicenter prospective cohort study
title_sort bedside counseling on complementary medicine as a new model in pediatric cancer care protocol of the sikom multicenter prospective cohort study
topic pediatric cancer
integrative cancer treatment
complementary medicine
safety
study protocol
url https://www.frontiersin.org/articles/10.3389/fped.2025.1567053/full
work_keys_str_mv AT laranowak bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT danielareis bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT rebeccabuttner bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT melanieschwermer bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT jenniferbals bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT daviddmartin bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT daviddmartin bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT thomasostermann bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT alfredlangler bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT alfredlangler bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT heidemariehaller bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT tychozuzak bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy
AT tychozuzak bedsidecounselingoncomplementarymedicineasanewmodelinpediatriccancercareprotocolofthesikommulticenterprospectivecohortstudy